FDA Inspection 1169830 — Alkem Laboratories Ltd., Bioequivalence Centre
The FDA completed an inspection of Alkem Laboratories Ltd., Bioequivalence Centre on April 14, 2022 in Navi Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 14, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Navi Mumbai (India)
Additional Details
Clinical BA/BE